WC
ANIP icon

Walthausen & Co’s ANI Pharmaceuticals ANIP Stock Holding History

Walthausen & Co’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-61,456
Closed -$2.83M – 142
2021
Q4 		$2.83M Buy
+61,456
New +$2.64M 0.74% 58

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Walthausen & Co's ANIP Position: Q1 2022 in Review

Walthausen & Co sold out of ANI Pharmaceuticals (ANIP) in Q1 2022, closing a stake of 61,456 shares — an estimated $2.83M sold.

Walthausen & Co first reported a position in ANIP in Q4 2021 and held it in 1 quarter. The position peaked at $2.83M in Q4 2021. 126 funds tracked by Wall St. Rank hold ANIP as of Q1 2022.

  • Walthausen & Co reported no remaining ANI Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Walthausen & Co sold 61,456 ANI Pharmaceuticals shares in Q1 2022, an estimated $2.83M.
  • Walthausen & Co first reported a position in ANI Pharmaceuticals in Q4 2021 and held it in 1 quarter.
  • Walthausen & Co's ANI Pharmaceuticals position peaked at $2.83M in Q4 2021.
  • 126 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2022.

Based on Walthausen & Co's 13F filing for Q1 2022, filed 11 May 2022.